TWI806621B - 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 - Google Patents

來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 Download PDF

Info

Publication number
TWI806621B
TWI806621B TW111119079A TW111119079A TWI806621B TW I806621 B TWI806621 B TW I806621B TW 111119079 A TW111119079 A TW 111119079A TW 111119079 A TW111119079 A TW 111119079A TW I806621 B TWI806621 B TW I806621B
Authority
TW
Taiwan
Prior art keywords
methylation
plasma
dna
tissue
cancer
Prior art date
Application number
TW111119079A
Other languages
English (en)
Chinese (zh)
Other versions
TW202305145A (zh
Inventor
煜明 盧
慧君 趙
君賜 陳
妙芬 倫
渭雯 陳
江培勇
Original Assignee
香港中文大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI806621(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by 香港中文大學 filed Critical 香港中文大學
Publication of TW202305145A publication Critical patent/TW202305145A/zh
Application granted granted Critical
Publication of TWI806621B publication Critical patent/TWI806621B/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
TW111119079A 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 TWI806621B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US61/703,512 2012-09-20
US13/842,209 2013-03-15
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
US61/830,571 2013-06-03

Publications (2)

Publication Number Publication Date
TW202305145A TW202305145A (zh) 2023-02-01
TWI806621B true TWI806621B (zh) 2023-06-21

Family

ID=50340462

Family Applications (4)

Application Number Title Priority Date Filing Date
TW111119079A TWI806621B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW102134227A TWI640634B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定
TW109112451A TWI784258B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW107123815A TWI707953B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定

Family Applications After (3)

Application Number Title Priority Date Filing Date
TW102134227A TWI640634B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定
TW109112451A TWI784258B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW107123815A TWI707953B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定

Country Status (28)

Country Link
EP (6) EP2898100B9 (cg-RX-API-DMAC7.html)
JP (6) JP6317354B2 (cg-RX-API-DMAC7.html)
KR (5) KR102148547B1 (cg-RX-API-DMAC7.html)
CN (2) CN104781422B (cg-RX-API-DMAC7.html)
AU (5) AU2013317708C1 (cg-RX-API-DMAC7.html)
BR (3) BR122021021825B1 (cg-RX-API-DMAC7.html)
CA (2) CA3122779A1 (cg-RX-API-DMAC7.html)
CY (1) CY1124139T1 (cg-RX-API-DMAC7.html)
DK (4) DK3536807T3 (cg-RX-API-DMAC7.html)
EA (1) EA201500327A1 (cg-RX-API-DMAC7.html)
ES (4) ES2665273T5 (cg-RX-API-DMAC7.html)
FI (2) FI3536807T3 (cg-RX-API-DMAC7.html)
HR (3) HRP20240210T1 (cg-RX-API-DMAC7.html)
HU (3) HUE066054T2 (cg-RX-API-DMAC7.html)
IL (4) IL313451A (cg-RX-API-DMAC7.html)
LT (2) LT4056712T (cg-RX-API-DMAC7.html)
MX (1) MX360034B (cg-RX-API-DMAC7.html)
MY (2) MY173356A (cg-RX-API-DMAC7.html)
NZ (2) NZ717423A (cg-RX-API-DMAC7.html)
PH (2) PH12015500547B1 (cg-RX-API-DMAC7.html)
PL (4) PL4056712T3 (cg-RX-API-DMAC7.html)
PT (4) PT2898100T (cg-RX-API-DMAC7.html)
SG (2) SG10201705198UA (cg-RX-API-DMAC7.html)
SI (1) SI4056712T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202100256T1 (cg-RX-API-DMAC7.html)
TW (4) TWI806621B (cg-RX-API-DMAC7.html)
WO (1) WO2014043763A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201501772B (cg-RX-API-DMAC7.html)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
ES2665273T5 (es) 2012-09-20 2023-10-02 Univ Hong Kong Chinese Determinación no invasiva de metiloma del feto o tumor de plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2685893T3 (es) * 2013-07-30 2018-10-15 Bgi Genomics Co., Limited Método para determinar la composición de ácidos nucleicos de una mezcla de ácidos nucleicos
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
WO2015126840A1 (en) * 2014-02-18 2015-08-27 Bionano Genomics, Inc. Improved methods of determining nucleic acid structural information
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
CA2945962C (en) * 2014-04-21 2023-08-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
MA39951A (fr) 2014-05-09 2017-03-15 Lifecodexx Ag Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées
TWI813141B (zh) * 2014-07-18 2023-08-21 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
ES2828279T3 (es) 2014-12-31 2021-05-25 Guardant Health Inc Detección y tratamiento de enfermedades que muestran heterogeneidad celular de enfermedad y sistemas y métodos para comunicar los resultados de las pruebas
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
CA2976303A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
EP3325663B1 (en) 2015-07-20 2020-08-19 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in dna mixture
EP3325664B1 (en) 2015-07-23 2021-12-29 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free dna
HK1248286A1 (zh) 2015-08-12 2018-10-12 The Chinese University Of Hong Kong 血浆dna的单分子测序
IL293187B2 (en) 2015-09-22 2024-03-01 Univ Hong Kong Chinese Accurate quantification of fetal dna fraction by shallow-depth sequencing of maternal plasma dna
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
EP4180532A1 (en) * 2015-11-09 2023-05-17 Roche Molecular Systems, Inc. Methods for determining the origin of dna molecules
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
AU2016370835B2 (en) 2015-12-17 2020-02-13 Illumina, Inc. Distinguishing methylation levels in complex biological samples
CN109072309B (zh) * 2016-02-02 2023-05-16 夸登特健康公司 癌症进化检测和诊断
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
US11078475B2 (en) * 2016-05-03 2021-08-03 Sinai Health System Methods of capturing cell-free methylated DNA and uses of same
US12300356B2 (en) 2016-05-04 2025-05-13 Queen's University At Kingston Cell-free detection of methylated tumour DNA
CN115161390B (zh) 2016-05-30 2025-12-05 香港中文大学 使用血液中的无细胞dna检测血液病症
AU2017285496B2 (en) * 2016-06-16 2023-02-23 The Johns Hopkins University Methods and system for epigenetic analysis
US11999998B2 (en) 2016-08-24 2024-06-04 Center For Excellence In Molecular Cell Science, Chinese Academy Of Sciences Modification of 5-methylcytosine catalyzed by Cmd1 enzyme and application thereof
MY205940A (en) * 2016-10-19 2024-11-21 Univ Hong Kong Chinese Gestational age assessment by methylation and size profiling of maternal plasma dna
SG11201903509QA (en) 2016-10-24 2019-05-30 Univ Hong Kong Chinese Methods and systems for tumor detection
IL315032A (en) * 2016-11-30 2024-10-01 Univ Hong Kong Chinese Analysis of cell-free dna in urine and other samples
WO2018112100A2 (en) * 2016-12-13 2018-06-21 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
CA3049442A1 (en) * 2017-01-11 2018-07-19 Quest Diagnostics Investments Llc Method for non-invasive prenatal screening for aneuploidy
CN110191964B (zh) * 2017-01-24 2023-12-05 深圳华大基因股份有限公司 确定生物样本中预定来源的游离核酸比例的方法及装置
MY197535A (en) 2017-01-25 2023-06-21 Univ Hong Kong Chinese Diagnostic applications using nucleic acid fragments
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
CA3063405A1 (en) * 2017-05-12 2018-11-15 President And Fellows Of Harvard College Universal early cancer diagnostics
CA3069668A1 (en) * 2017-07-12 2019-01-17 Ande Corporation Pattern recognition system
BR112020000681A2 (pt) * 2017-07-12 2020-07-14 University Health Network detecção e classificação de cancro utilizando análise de metilome
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
ES2959360T3 (es) * 2017-07-26 2024-02-23 Univ Hong Kong Chinese Mejora del cribado del cáncer mediante ácidos nucleicos víricos acelulares
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
EP4026915B1 (en) 2017-09-28 2023-10-25 Grail, LLC Enrichment of short nucleic acid fragments in sequencing library preparation
US11168356B2 (en) * 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
SG11202008957VA (en) * 2018-03-15 2020-10-29 Grail Inc Tissue-specific methylation marker
CN112236520B (zh) 2018-04-02 2025-01-24 格里尔公司 甲基化标记和标靶甲基化探针板
US11681953B2 (en) * 2018-04-13 2023-06-20 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay development and testing
EP3781709A4 (en) * 2018-04-16 2022-11-30 Grail, LLC Systems and methods for determining tumor fraction in cell-free nucleic acid
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
CA3111887A1 (en) 2018-09-27 2020-04-02 Grail, Inc. Methylation markers and targeted methylation probe panel
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
GB2615955B (en) 2018-11-21 2023-11-22 Agilent Technologies Inc Methods for targeted nucleic acid library formation
DK3899018T3 (da) * 2018-12-19 2024-01-08 Univ Hong Kong Chinese Cellefri DNA-endeegenskaber
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
ES2994567T3 (en) 2019-02-05 2025-01-27 Grail Inc Detecting cancer, cancer tissue of origin, and/or a cancer cell type
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
CN114072527B (zh) 2019-03-25 2025-03-04 香港中文大学 确定循环核酸的线性和环状形式
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
US20220243263A1 (en) * 2019-05-03 2022-08-04 Cornell University Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
EP4020484A4 (en) * 2019-08-19 2023-08-30 Green Cross Genome Corporation METHOD FOR DETECTING A CHROMOSOME ABNORMALITY USING INFORMATION CONCERNING THE DISTANCE BETWEEN NUCLEIC ACID FRAGMENTS
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
CN115836349A (zh) * 2019-11-27 2023-03-21 格里尔公司 用于评估纵向生物特征数据的系统和方法
JP7732991B2 (ja) 2020-01-31 2025-09-02 アジレント・テクノロジーズ・インク 標的化された核酸捕捉のためのシステムおよび方法
KR20220148196A (ko) * 2020-02-10 2022-11-04 팔로젠 인코포레이티드 나노포어 디바이스 및 이를 사용하여 하전된 입자들을 검출하고 분류하는 방법
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
WO2021174072A1 (en) * 2020-02-28 2021-09-02 Grail, Inc. Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
EP4247973A4 (en) * 2020-11-19 2024-09-11 Nucleix Ltd. DETECTION OF METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH-THROUGHPUT SEQUENCING
AU2021401813A1 (en) * 2020-12-17 2023-07-06 Dana-Farber Cancer Institute, Inc. Methods of cancer detection using extraembryonically methylated cpg islands
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
US20240371467A1 (en) * 2021-09-28 2024-11-07 Act Genomics (ip) Limited Methylation biomarker selection apparatuses and methods
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
EP4384633A1 (en) * 2021-11-04 2024-06-19 Universal Diagnostics, S.A. Systems and methods for preparing biological samples for genetic sequencing
IL314466A (en) 2022-02-07 2024-09-01 Centre For Novostics Fragmentation for measuring methylation and disease
EP4482985A2 (en) * 2022-02-22 2025-01-01 Flagship Pioneering Innovations VI, LLC Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN116555426B (zh) * 2023-05-04 2024-07-12 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒及数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011092592A2 (en) * 2010-01-26 2011-08-04 Nipd Genetics Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
TWI640634B (zh) * 2012-09-20 2018-11-11 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
DE60207979T2 (de) † 2002-03-05 2006-09-28 Epigenomics Ag Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
CA2506243A1 (en) † 2002-11-19 2004-06-03 Amgen Inc. Amplified genes involved in cancer
US20060183128A1 (en) † 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
CA2559209C (en) * 2004-03-08 2016-06-07 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
WO2006128192A2 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
TWI335354B (en) * 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
EP2173897A2 (en) 2007-06-19 2010-04-14 Oncomethylome Sciences SA Improved urine sample collecting and processing
EP3892736A1 (en) 2007-07-23 2021-10-13 The Chinese University of Hong Kong Determining a nucleic acid sequence imbalance
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
US20120208711A1 (en) 2009-10-02 2012-08-16 Centre For Addiction And Mental Health Method for Analysis of DNA Methylation Profiles of Cell-Free Circulating DNA in Bodily Fluids
CN102770558B (zh) * 2009-11-05 2016-04-06 香港中文大学 由母本生物样品进行胎儿基因组的分析
CA2780016C (en) 2009-11-06 2017-09-19 The Chinese University Of Hong Kong Size-based genomic analysis
CA2786564A1 (en) † 2010-01-19 2011-07-28 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
KR101903547B1 (ko) † 2010-04-29 2018-10-04 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 게놈 모델에 대한 데이터 통합을 이용하는 경로 인지 알고리즘 （ｐａｒａｄｉｇｍ）
GB201007944D0 (en) * 2010-05-12 2010-06-30 Univ Aberystwyth Methods
US10167513B2 (en) 2010-05-25 2019-01-01 The Johns Hopkins University Compositions and methods for detecting a neoplasia
MX361944B (es) * 2010-07-23 2018-12-19 President And Fellows Of Harvard College Star Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
US20120021919A1 (en) * 2010-07-23 2012-01-26 Thomas Scholl Identification of Differentially Represented Fetal or Maternal Genomic Regions and Uses Thereof
WO2012031329A1 (en) * 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
KR102040307B1 (ko) † 2010-11-30 2019-11-27 더 차이니즈 유니버시티 오브 홍콩 암과 연관된 유전적 또는 분자적 이상들의 검출

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011092592A2 (en) * 2010-01-26 2011-08-04 Nipd Genetics Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
TWI640634B (zh) * 2012-09-20 2018-11-11 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定
TWI707953B (zh) * 2012-09-20 2020-10-21 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TWI784258B (zh) * 2012-09-20 2022-11-21 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定

Also Published As

Publication number Publication date
FI4056712T3 (fi) 2024-08-29
KR20230145530A (ko) 2023-10-17
PL3536807T3 (pl) 2024-05-06
PT3536807T (pt) 2024-02-01
AU2022201026B2 (en) 2025-04-03
MY187444A (en) 2021-09-22
PH12015500547A1 (en) 2015-05-04
EP4335929A3 (en) 2024-05-29
EP4335929A2 (en) 2024-03-13
TW201907013A (zh) 2019-02-16
PT2898100T (pt) 2018-02-26
JP6683752B2 (ja) 2020-04-22
AU2025205087A1 (en) 2025-07-24
HUE068129T2 (hu) 2024-12-28
EP3354747A1 (en) 2018-08-01
SMT202100256T1 (it) 2021-05-07
EP3354747B1 (en) 2021-02-17
EP2898100A4 (en) 2016-05-11
TWI784258B (zh) 2022-11-21
IL237495A0 (en) 2015-04-30
BR112015006183B1 (pt) 2022-04-26
BR122021021823B1 (pt) 2023-04-25
ES2665273T5 (es) 2023-10-02
KR20220065034A (ko) 2022-05-19
MY173356A (en) 2020-01-21
EP2898100B2 (en) 2023-05-10
AU2020200128A1 (en) 2020-01-30
AU2017251832A1 (en) 2017-11-16
NZ717423A (en) 2017-08-25
IL299444B2 (en) 2024-11-01
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
KR20210120124A (ko) 2021-10-06
MX360034B (es) 2018-10-19
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
HUE066054T2 (hu) 2024-07-28
EP4056712B1 (en) 2024-07-31
DK3354747T3 (da) 2021-04-19
ES2994426T3 (en) 2025-01-23
JP7594817B2 (ja) 2024-12-05
JP2025026936A (ja) 2025-02-26
DK4056712T3 (da) 2024-08-26
KR102148547B1 (ko) 2020-08-26
HUE053822T2 (hu) 2021-07-28
PL2898100T5 (pl) 2023-11-06
WO2014043763A1 (en) 2014-03-27
NZ706269A (en) 2016-08-26
CA2884066A1 (en) 2014-03-27
HRP20241142T1 (hr) 2024-11-22
HK1207124A1 (en) 2016-01-22
AU2013317708B2 (en) 2017-08-03
EP2898100A1 (en) 2015-07-29
JP2022031753A (ja) 2022-02-22
IL237495B (en) 2019-09-26
MX2015003571A (es) 2015-06-22
LT3354747T (lt) 2021-04-12
TW202043483A (zh) 2020-12-01
HK1257868A1 (en) 2019-11-01
SI4056712T1 (sl) 2024-10-30
TW201418474A (zh) 2014-05-16
JP2020108400A (ja) 2020-07-16
AU2017251832B2 (en) 2019-10-10
EA201500327A1 (ru) 2015-07-30
KR102307424B1 (ko) 2021-09-29
CN104781422B (zh) 2023-12-26
EP4056712A1 (en) 2022-09-14
IL299444A (en) 2023-02-01
DK2898100T4 (da) 2023-07-24
EP3536807B1 (en) 2023-11-29
SG11201501927VA (en) 2015-04-29
LT4056712T (lt) 2024-09-10
FI3536807T3 (fi) 2024-02-01
HRP20240210T1 (hr) 2024-05-10
EP2898100B1 (en) 2017-11-22
KR20150082228A (ko) 2015-07-15
AU2013317708C1 (en) 2017-11-23
ES2862726T3 (es) 2021-10-07
KR20200085928A (ko) 2020-07-15
KR102587176B1 (ko) 2023-10-06
BR112015006183A2 (pt) 2017-07-04
CN104781422A (zh) 2015-07-15
ES2665273T3 (es) 2018-04-25
JP2015536639A (ja) 2015-12-24
EP3839065A1 (en) 2021-06-23
CA3122779A1 (en) 2014-03-27
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
CN117757932A (zh) 2024-03-26
BR122021021825B1 (pt) 2022-05-24
EP2898100B9 (en) 2023-08-02
DK3536807T3 (da) 2024-02-05
AU2020200128B2 (en) 2021-11-18
JP6985753B2 (ja) 2021-12-22
IL268512A (en) 2019-09-26
JP2018121644A (ja) 2018-08-09
ZA201501772B (en) 2016-10-26
PH12015500547B1 (en) 2024-05-17
CA2884066C (en) 2021-08-10
JP2024009833A (ja) 2024-01-23
SG10201705198UA (en) 2017-07-28
AU2013317708A1 (en) 2015-04-09
HK1206797A1 (en) 2016-01-15
PL4056712T3 (pl) 2024-12-02
IL313451A (en) 2024-08-01
HRP20210716T1 (hr) 2021-06-11
TW202305145A (zh) 2023-02-01
CY1124139T1 (el) 2022-05-27
IL268512B2 (en) 2023-06-01
DK2898100T3 (en) 2018-02-26
TWI707953B (zh) 2020-10-21
PL3354747T3 (pl) 2021-07-26
PL2898100T3 (pl) 2018-06-29
TW202334438A (zh) 2023-09-01
AU2022201026A1 (en) 2022-03-10
TWI640634B (zh) 2018-11-11
JP6317354B2 (ja) 2018-04-25
ES2969567T3 (es) 2024-05-21

Similar Documents

Publication Publication Date Title
JP7594817B2 (ja) 血漿による胎児または腫瘍のメチロームの非侵襲的決定
US20250349386A1 (en) Non-invasive detection of tissue abnormality using methylation
TWI901957B (zh) 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
HK40055436A (en) Non-invasive determination of methylome of tumor from plasma
HK40013800B (en) Non-invasive determination of methylome of tumor from plasma
HK40013800A (en) Non-invasive determination of methylome of tumor from plasma
HK1257868B (en) Non-invasive determination of methylome of tumor from plasma
HK1206797B (en) Non-invasive determination of methylome of fetus or tumor from plasma
HK1207124B (zh) 从血浆无创测定胎儿或肿瘤的甲基化组